Pharsight

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8133883	WYETH PHARMS	Compositions containing piperacillin and tazobactam useful for injection	Apr, 2023 (5 months ago)
US6900184	WYETH PHARMS	Compositions containing pipercillin and tazobactam useful for injection	Apr, 2023 (5 months ago)
US7915229	WYETH PHARMS	Compositions containing piperacillin and tazobactam useful for injection	Apr, 2023 (5 months ago)

Zosyn is owned by Wyeth Pharms.

Zosyn contains Piperacillin Sodium; Tazobactam Sodium.

Zosyn has a total of 3 drug patents out of which 3 drug patents have expired.

Expired drug patents of Zosyn are:

Zosyn was authorised for market use on 22 October, 1993.

Zosyn is available in injectable;injection dosage forms.

Zosyn can be used as method of treating bacterial infections.

The generics of Zosyn are possible to be released after 14 April, 2023.

Market Authorisation Date: 22 October, 1993

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

Strength	Submission Date	ANDA(s) Filed	First applicant approval	Last patent expiry	180 day status
2.25 g/vial 3.375 g/vial 4.5 g/vial
12 g/1.5 g per vial (pharmacy bulk)	06 Dec, 2011	1	29 Oct, 2014	14 Apr, 2023	Eligible
36 mg/4.5 g per vial (pharmacy bulk)		1	15 Sep, 2009	14 Apr, 2023	Eligible

ZOSYN family patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic